1. Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Bunkyō-ku, Tokyo, Japan;
2. Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Tokyo, Japan;
3. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;
4. Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan;
5. Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan;
6. Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan;
7. Aichi Cancer Center Research Institute, Nagoya, Japan;
8. Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
9. HLA Foundation Laboratory, Kyoto, Japan;
10. Affymetrix, Santa Clara, California;
11. Medical Institute of Bioregulation, Kyusyu University, Fukuoka, Japan;
12. Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University, Nagoya, Japan; and
13. Institute for Advanced Study, Kyusyu University, Fukuoka, Japan